12.07.11
Marken has launched Solo, a web-based system used to manage the regulatory, inventory and operational supply chain complexities of clinical trials. The system is designed to manage all aspects of Marken’s global depot network including receipt of clinical supplies and kits, dispatches, returns, warehouse movements and QA releases. According to the company, Solo is a secure, validated, web-based system that is fully accessible to clients on a 24/7 basis from any location in the world. Marken designed Solo to integrate with multiple client-directed IXR (Interactive Reporting) systems.
“We are pleased to offer this new system to our growing number of pharmaceutical clients,” said Frank Wright, interim president, Clinical Trials Distribution at Marken. “Solo is a very unique and fit-for-purpose application that incorporates all of our client’s requirements for remote storage and distribution of their clinical trial supplies. We are also excited to be launching Solo as we manage an increasing number of depots around the world.”
“We welcome the pharmaceutical industry to discuss their global distribution needs for pharmaceutical logistics and supply chain management with us,” said Wes Wheeler, Marken’s chief executive officer. “We are uniquely positioned to grow with the industry’s need for management of time critical, temperature critical and complex shipments of their clinical supplies. We are committed to providing fully validated facilities in strategic centers around the world from which clinical trials can be managed.”
“We are pleased to offer this new system to our growing number of pharmaceutical clients,” said Frank Wright, interim president, Clinical Trials Distribution at Marken. “Solo is a very unique and fit-for-purpose application that incorporates all of our client’s requirements for remote storage and distribution of their clinical trial supplies. We are also excited to be launching Solo as we manage an increasing number of depots around the world.”
“We welcome the pharmaceutical industry to discuss their global distribution needs for pharmaceutical logistics and supply chain management with us,” said Wes Wheeler, Marken’s chief executive officer. “We are uniquely positioned to grow with the industry’s need for management of time critical, temperature critical and complex shipments of their clinical supplies. We are committed to providing fully validated facilities in strategic centers around the world from which clinical trials can be managed.”
